Search Within

Tiffany A Traina

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (34)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Biostatistics Service (85)
  2. Breast Medicine Service (85)
  3. Department of Medicine (85)
  4. Epidemiology and Biostatistics (85)
  5. Solid Tumor Oncology Division (85)
  6. Survivorship Research (85)

More Groups

People
  1. Sujata Patil (62)
  2. Clifford Hudis (47)
  3. Larry Norton (33)
  4. Ayca Gucalp (24)
  5. Chau Dang (20)
  6. Mark Robson (20)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Cancer Research (15)
  3. Breast Cancer Research and Treatment (7)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (19)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Oxford University Press (4)
  6. John Wiley & Sons (3)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)
    Meeting Abstract

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • EGFR and P53 expression in androgen receptor (AR)-positive, triple negative breast cancer (TNBC)
    Meeting Abstract

    Gucalp, A.; Gupta, G.; Patil, S.; Wen, Y. H.; Akram, M.; Brogi, E.; Powell, S.; Ho, A.; Hudis, C. A.; Traina, T. A.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
    Journal Article

    Ho, A. Y.; Gupta, G.; King, T. A.; Perez, C. A.; Patil, S. M.; Rogers, K. H.; Wen, Y. H.; Brogi, E.; Morrow, M.; Hudis, C. A.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Androgen receptor (AR) expression in a cohort of patients (pts) with triple negative breast cancer (TNBC)
    Meeting Abstract

    Gucalp, A.; Gupta, G.; Patil, S.; Wen, Y. H.; Akram, M.; Brogi, E.; Powell, S. N.; Ho, A. Y.; Hudis, C. A.; Traina, T. A.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Targeting tumor angiogenesis in combination with endocrine therapy in patients with hormone-receptor positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Traina, T.; Rugo, H.; Geneus, S.; Patil, S.; Hudis, C.; Dickler, M. N.
    European Journal of Clinical and Medical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Sparano, J. A.; Caravelli, J.; Santamauro, J.; Patil, S.; Abbruzzi, A.; Pellegrino, C.; Bromberg, J.; Dang, C.; Theodoulou, M.; more...
    Clinical Breast Cancer (2011)

    Fulltext@MSK | Save
  • Black race is associated with higher risk of locoregional recurrence after breast-conserving therapy in patients with triple negative breast cancer
    Meeting Abstract

    Perez, C. A.; Gupta, G.; King, T. A.; Rogers, K. H.; McLane, A.; Patil, S.; Traina, T. A.; Robson, M.; McCormick, B.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer
    Journal Article

    Gajria, D.; Feigin, K.; Tan, L. K.; Patil, S.; Geneus, S.; Theodoulou, M.; Norton, L.; Hudis, C. A.; Traina, T. A.
    Cancer (2011)

    Fulltext@MSK | Save
  • Determinants of outcome in elderly patients with positive sentinel lymph nodes
    Journal Article

    Karam, A. K.; Hsu, M.; Patil, S.; Stempel, M.; Traina, T. A.; Ho, A. Y.; Cody, H. S.; Morrow, M.; Gemignani, M. L.
    American Journal of Surgery (2011)

    Fulltext@MSK | Save